Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
COYA is expected to report earnings to rise 63.89% to -58 cents per share on November 05
Q3'25
Est.
$-0.59
Q2'25
Missed
by $0.49
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.22
Q3'24
Beat
by $0.10
The last earnings report on August 12 showed earnings per share of -36 cents, missing the estimate of 12 cents. With 38.72K shares outstanding, the current market capitalization sits at 109.72M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. COYA showed earnings on August 12, 2025. You can read more about the earnings report here.